Cancer Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others)  Analysis and Forecast by 2021

Cancer Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others) Analysis and Forecast by 2021

Comments Off on Cancer Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others) Analysis and Forecast by 2021

According to the report, global cancer drugs market was valued at approximately USD 112.90 billion in 2015 and is expected to generate revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021.Cancer is defined as a disease which occurs as a result of changes in a group of normal cells within the body which leads to uncontrolled growth resulting in the formation of lump called a tumor; (except for cancer of the blood). If left untreated, tumors can grow and spread into the surrounding normal tissue, or to other parts of the body via lymphatic systems and the bloodstream, and can in turn severely impact the functioning of the digestive, nervous and circulatory systems.

 

According to the report, global cancer drugs market was valued at approximately USD 112.90 billion in 2015 and is expected to generate revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021.

Cancer can be defined as uncontrolled growth of the cell. Cancer starts when cells grow out of control and outnumber normal cells. Uncontrolled growth of cell leads to the formation of the tumor which can interfere with the nervous, digestive, and circulatory systems. Tumor cell releases hormones that alter body functions. Tumors that stay in one location and show limited growth are considered as benign cancer. Whereas, the cancerous cell which flows throughout the body part, using blood, lymph, and destroying the healthy tissue are called malignant cancer. According to the American Cancer Society, cancer is the second most common cause of death in the U.S. and accounts for nearly 1 of every 4 deaths. The World Health Organization estimates that, worldwide, there were 14 million new cancer cases and 8.2 million cancer-related deaths in 2012. There are over 200 different types of cancer, and each of which is classified by the type of cell that is initially affected. Various types of cancer include prostate cancer, blood cancer, lungs cancer etc. The treatment of cancer has become of prime importance owing to increase in a number of global cancer patients. Different types of drugs are administered to cancer patients depending upon therapy used to treat the patient and type of cancer.

Growing incidences of target disease such as lung cancer, breast cancer, cervical cancer, etc. are expected to be the major driver for the global cancer drugs market. In addition, increasing research and development on biological and targeted drug therapies for the treatment of cancer coupled along with the expiration of patents is expected to trigger the growth of global cancer drugs industry in the coming years. However, the high price of drug development and stringent regulatory policies coupled along with the possibility of failure may pose the challenge to cancer drugs market. Nevertheless, increasing focus on personalized medicine coupled along with huge investment in anti-cancer drugs research across the globe are expected to act an opportunity for cancer drugs market in near future.

Global Cancer Drugs Market

Based on therapeutics, cancer drugs market has been segmented into immunotherapy, targeted therapy, chemotherapy, hormone therapy and others. Immunotherapy segment is expected to grow at the fastest rate during the forecast period. The cancer drugs market is segmented based on cancer type into breast cancer, blood cancer, gastrointestinal cancer, prostate cancer, skin cancer, lung cancer and others  In terms of revenue, blood cancer segment dominated the market in 2015.

North America is expected to remain the dominant region over the forecast period. Increasing healthcare awareness is expected to boost the market in this region. Europe was the second largest market followed by Asia-Pacific. North America is expected to show fastest growth rate during the forecast period while Asia-Pacific market is projected to grow at a moderate rate during the forecast period. The Middle East and Africa, and Latin America are also expected to experience noticeable growth in the years to come.

Some of the key players in cancer drugs market include Bayer, GlaxoSmithKline, Novartis, Sanofi and Pfizer, Amgen, Merck, Bristol-Myers Squibb, Celgene Corporation, Ariad Pharmaceuticals, Eli Lilly, Hoffmann-La Roche Ltd, Boehringer Ingelheim GmbH, Johnson and Johnson and Teva Pharmaceuticals among others.

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global cancer drugs market, 2015 – 2021 (USD Billion)
    • 2.2. Global cancer drugs market : Snapshot
  • Chapter 3. Cancer drugs– Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global cancer drugs market drivers: Impact analysis
      • 3.2.2. Rising incidences of target disease
      • 3.2.3. Expiration of patents
    • 3.3. Market restraints
      • 3.3.1. Global cancer drugs market restraints: Impact analysis
      • 3.3.2. High price of drug development
    • 3.4. Opportunities
      • 3.4.1. Increasing focus on personalized medicine
    • 3.5. Porter’s five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by therapy segment
      • 3.6.2. Market attractiveness analysis, by cancer type segment
      • 3.6.3. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Cancer Drugs Market – Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global cancer Drugs market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Therapy Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Therapy and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Therapy Portfolio
    • 4.5. Patent Analysis (2011-2016)
      • 4.5.1. Patent Trend
      • 4.5.2. Patent Share by company
      • 4.5.3. By Region
  • Chapter 5. Global Cancer drugs Market – Therapy Segment Analysis
    • 5.1. Global cancer drugs market: Therapy overview
      • 5.1.1. Global cancer drugs market revenue share, by Therapy, 2015 and 2021
    • 5.2. Immunotherapy
      • 5.2.1. Global Immunotherapy market , 2015 – 2021(USD Billion)
    • 5.3. Targeted Therapy
      • 5.3.1. Global Targeted Therapy market , 2015 – 2021(USD Billion)
    • 5.4. Chemotherapy
      • 5.4.1. Global Chemotherapy market , 2015 – 2021(USD Billion)
    • 5.5. Hormone Therapy
      • 5.5.1. Global Hormone Therapy market , 2015 – 2021(USD Billion)
    • 5.6. Others
      • 5.6.1. Global Others market , 2015 – 2021(USD Billion)
  • Chapter 6. Global Cancer Drugs Market – Cancer type Segment Analysis
    • 6.1. Global cancer drugs market: Cancer type overview
      • 6.1.1. Global cancer drugs market revenue share, by cancer type, 2015 and 2020
    • 6.2. Breast Cancer
      • 6.2.1. Global cancer drugs market for Breast Cancer, 2015 – 2021 (USD Billion)
    • 6.3. Blood Cancer
      • 6.3.1. Global cancer drugs market for Blood Cancer, 2015 – 2021(USD Billion)
    • 6.4. Gastrointestinal Cancer
      • 6.4.1. Global cancer drugs market for Gastrointestinal Cancer, 2015 – 2021 (USD Billion)
    • 6.5. Prostate Cancer
      • 6.5.1. Global cancer drugs market for Prostate Cancer, 2015 – 2021(USD Billion)
    • 6.6. Skin Cancer
      • 6.6.1. Global cancer drugs market for Skin Cancer, 2015 – 2021(USD Billion)
    • 6.7. Lung Cancer
      • 6.7.1. Global cancer drugs market for Lung Cancer, 2015 – 2021(USD Billion)
    • 6.8. Others
      • 6.8.1. Global cancer drugs market for other cancer type , 2015 – 2021 (USD Billion)
  • Chapter 7. Global Cancer drugs Market – Regional Segment Analysis
    • 7.1. Global cancer drugs market: Regional overview
      • 7.1.1. Global cancer drugs market revenue share, by region, 2015 and 2021
    • 7.2. North America
      • 7.2.1. North America cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
      • 7.2.2. North America cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
        • 7.2.3.2. U.S. cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
      • 7.3.2. Europe cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
      • 7.3.3. Germany
        • 7.3.3.1. Germany cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
        • 7.3.3.2. Germany cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
      • 7.3.4. France
        • 7.3.4.1. France cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
        • 7.3.4.2. France cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
      • 7.3.5. UK
        • 7.3.5.1. UK cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
        • 7.3.5.2. UK cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific cancer drugs market revenue, by Therapy, 2015 – 2021, (USD Billion)
      • 7.4.2. Asia Pacific cancer drugs market revenue, by cancer type, 2015 – 2021, (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
        • 7.4.3.2. China cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
        • 7.4.4.2. Japan cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
        • 7.4.5.2. India cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
      • 7.5.2. Latin America cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
        • 7.5.3.2. Brazil cancer drugs market revenue, by cancer type, 2015 – 2021 (USD Billion)
    • 7.6. Middle East and Africa
      • 7.6.1. Middle East and Africa cancer drugs market revenue, by Therapy, 2015 – 2021 (USD Billion)
      • 7.6.2. Middle East and Africa cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
  • Chapter 8. Company Profile
    • 8.1. Bayer
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Therapy portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. GlaxoSmithKline
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Therapy portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Novartis
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Therapy portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Sanofi
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Therapy portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Pfizer
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Therapy portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Amgen
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Therapy portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Merck
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Therapy portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Bristol-Myers Squibb
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Therapy portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Celgene Corporation
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Therapy portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. Ariad Pharmaceuticals
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Therapy portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments
    • 8.11. Eli Lilly
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Therapy portfolio
      • 8.11.4. Business strategy
      • 8.11.5. Recent developments
    • 8.12. Hoffmann-La Roche Ltd
      • 8.12.1. Overview
      • 8.12.2. Financials
      • 8.12.3. Therapy portfolio
      • 8.12.4. Business strategy
      • 8.12.5. Recent developments
    • 8.13. Boehringer Ingelheim GmbH
      • 8.13.1. Overview
      • 8.13.2. Financials
      • 8.13.3. Therapy portfolio
      • 8.13.4. Business strategy
      • 8.13.5. Recent developments
    • 8.14. Johnson and Johnson
      • 8.14.1. Overview
      • 8.14.2. Financials
      • 8.14.3. Therapy portfolio
      • 8.14.4. Business strategy
      • 8.14.5. Recent developments
    • 8.15. Teva Pharmaceuticals
      • 8.15.1. Overview
      • 8.15.2. Financials
      • 8.15.3. Therapy portfolio
      • 8.15.4. Business strategy
      • 8.15.5. Recent developments

List of Figures

1. Market research process
2. Market research methodology
3. Global cancer drugs market revenue, 2015 – 2021(USD Billion)
4. Porter’s five forces analysis
5. Cancer drugs Market attractiveness analysis, by therapy segment
6. Cancer drugs: Market attractiveness analysis, by cancer type segment
7. Cancer drugs: Market attractiveness analysis, by regional segment
8. Company market share analysis, 2015
9. Patent trend between 2011 -2016
10. Patent share by company between 2011 – 2016
11. Patent share by region between 2011 – 2016
12. Global cancer drugs market revenue share by Therapy, 2015 and 2021
13. Global Immunotherapy market, 2015 – 2021 (USD Billion)
14. Global Targeted Therapy market, 2015 – 2021(USD Billion)
15. Global Chemotherapy market, 2015 – 2021 (USD Billion)
16. Global Hormone Therapy market, 2015 – 2021 (USD Billion)
17. Global Others market, 2015 – 2021 (USD Billion)
18. Global cancer drugs market revenue share by cancer type, 2015 and 2021
19. Global cancer drugs market for Breast Cancer, 2015 – 2021, (USD Billion)
20. Global cancer drugs market for Blood Cancer, 2015 – 2021, (USD Billion)
21. Global cancer drugs market for Gastrointestinal Cancer, 2015 – 2021, (USD Billion)
22. Global cancer drugs market for Prostate Cancer, 2015 – 2021, (USD Billion)
23. Global cancer drugs market for Skin Cancer, 2015 – 2021, (USD Billion)
24. Global cancer drugs market for Lung Cancer, 2015 – 2021, (USD Billion)
25. Global cancer drugs market for other cancer type, 2015 – 2021, (USD Billion)


List of Tables

1. Cancer drugs market: Market snapshot
2. Drivers of global cancer drugs market: Impact analysis
3. Restraints of global cancer drugs market: Impact analysis
4. North America cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
5. North America cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
6. U.S. cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
7. U.S. cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
8. Germany cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
9. Germany cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
10. France cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
11. France cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
12. UK cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
13. UK cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
14. Asia Pacific cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
15. Asia Pacific cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
16. China cancer drugs market revenue, by Therapy 2015 – 2021(USD Billion)
17. China cancer drugs market revenue, by cancer type 2015 – 2021(USD Billion)
18. Japan cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
19. Japan cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
20. India cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
21. India cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
22. Latin America cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
23. Latin America cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
24. Brazil cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
25. Brazil cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)
26. Middle East and Africa cancer drugs market revenue, by Therapy, 2015 – 2021(USD Billion)
27. Middle East and Africa cancer drugs market revenue, by cancer type, 2015 – 2021(USD Billion)

* Indicates required field.

Your Name*

Your Email*

Telephone Number*

Name of company*

Country Name*

How can we help you?

Prove You are Human*

captcha
Enter Capcha Image Properly



Share this Post

Related Posts

Checking...

Ouch! There was a server error.
Retry »

Sending message...

Enquiry Form

Fill in the form below and we will be in touch soon

Create Account



Log In Your Account